{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:48:44Z","timestamp":1762098524223},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijcard.2016.01.154","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T22:01:11Z","timestamp":1452290471000},"page":"208-210","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?"],"prefix":"10.1016","volume":"207","author":[{"given":"Max","family":"Liebregts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus M.","family":"Bol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Willem","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariska","family":"Lieuw-a-Fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin H.","family":"Heijmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.01.154_bb0005","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.01.154_bb0010","first-page":"896","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0015","first-page":"630","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ccd.10767","article-title":"Ventricular septal rupture following nonsurgical septal reduction for hypertrophic cardiomyopathy: treatment with percutaneous closure","volume":"61","author":"Aroney","year":"2004","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.101.1.27","article-title":"Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) trial investigators","volume":"101","author":"Crenshaw","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.01.154_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ophtha.2008.08.009","article-title":"Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery","volume":"116","author":"Palanca-Capistrano","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijcard.2016.01.154_bb0035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-5-19","article-title":"Common threads in cardiac fibrosis, infarct scar formation, and wound healing","volume":"5","author":"Czubryt","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.ijcard.2016.01.154_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/mol.64.3.707","article-title":"5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase\/activator protein-1 activation","volume":"64","author":"Wendling","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0050","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMra020228","article-title":"Ventricular septal rupture after acute myocardial infarction","volume":"347","author":"Birnbaum","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.154_bb0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0735-1097(00)00878-0","article-title":"Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK trial registry. Should we emergently revascularize occluded coronaries in cardiogenic shocK?","volume":"36","author":"Menon","year":"2000","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316301528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316301528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T09:24:26Z","timestamp":1556357066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316301528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":11,"alternative-id":["S0167527316301528"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.154","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}